Exact Mass: 326.1397

Exact Mass Matches: 326.1397

Found 236 metabolites which its exact mass value is equals to given mass value 326.1397, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Clozapine

6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaene

C18H19ClN4 (326.1298)


A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. [PubChem] N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AH - Diazepines, oxazepines, thiazepines and oxepines D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 2841 CONFIDENCE standard compound; INTERNAL_ID 1600 Clozapine (HF 1854) is an antipsychotic used for the research of schizophrenia. Clozapine has high affinity for a number of neuroreceptors. Clozapine is a potent antagonist of dopamine D2 with a Ki of 75 nM. Clozapine inhibits the muscarinic M1 receptor and serotonin 5HT2A receptor with Kis of 9.5 nM and 4 nM, respectively[1][2][3]. Clozapine is also a potent and selective agonist at the muscarinic M4 receptor (EC50=11 nM)[4].

   

2,2,4-Trimethyl-3-(4-fluorophenyl)-2H-1-benzopyran-7-ol acetate

2,2,4-Trimethyl-3-(4-fluorophenyl)-2H-1-benzopyran-7-ol acetate

C20H19FO3 (326.1318)


   

Hinokitiol glucoside

Hinokitiol glucoside; beta-Thujaplicin 2-O-beta-D-glucoside

C16H22O7 (326.1365)


   

Meptin

Procaterol hydrochloride

C16H22N2O3. HCl (326.1397)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists Same as: D02404

   

Acepromazine

1-{10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethan-1-one

C19H22N2OS (326.1453)


Acepromazine is only found in individuals that have used or taken this drug. It is one of the phenothiazine derivative psychotropic drugs, used little in humans, however frequently in animals as a sedative and antiemetic.Acepromazine acts as an antagonist (blocking agent) on different postsysnaptic receptors -on dopaminergic-receptors (subtypes D1, D2, D3 and D4 - different antipsychotic properties on productive and unproductive symptoms), on serotonergic-receptors (5-HT1 and 5-HT2, with anxiolytic, antidepressive and antiaggressive properties as well as an attenuation of extrapypramidal side-effects, but also leading to weight gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors (antisympathomimetic properties, lowering of blood pressure, reflex tachycardia, vertigo, sedation, hypersalivation and incontinence as well as sexual dysfunction, but may also attenuate pseudoparkinsonism - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia, ECG-changes and loss of memory, but the anticholinergic action may attenuate extrapyramidal side-effects). N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

Aceprometazine

1-{10-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethan-1-one

C19H22N2OS (326.1453)


Aceprometazine (INN) is a prescription drug with neuroleptic and anti-histamine properties. It is not widely prescribed. It may be used in combination with meprobamate for the treatment of sleep disorders. This combination is available in France under the trade name Mepronizine. [Wikipedia] D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

Citrusin C

2-(hydroxymethyl)-6-[2-methoxy-4-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

C16H22O7 (326.1365)


Constituent of leaves of white flowered perilla Perilla frutescens variety forma viridis and the leaves of Dalmatian sage (Salvia officinalis). Flavouring agent. Citrusin C is found in lemon, herbs and spices, and common sage. Citrusin C is found in common sage. Citrusin C is a constituent of leaves of white flowered perilla Perilla frutescens var. forma viridis and the leaves of Dalmatian sage (Salvia officinalis). Citrusin C is a flavouring agent.

   

1-Methoxy-3-(4-hydroxyphenyl)-2E-propenal 4'-glucoside

2-(hydroxymethyl)-6-{4-[(1E)-3-methoxyprop-1-en-1-yl]phenoxy}oxane-3,4,5-triol

C16H22O7 (326.1365)


1-Methoxy-3-(4-hydroxyphenyl)-2E-propenal 4-glucoside is found in herbs and spices. 1-Methoxy-3-(4-hydroxyphenyl)-2E-propenal 4-glucoside is a constituent of fennel (Foeniculum vulgare) Constituent of fennel (Foeniculum vulgare). 1-Methoxy-3-(4-hydroxyphenyl)-2E-propenal 4-glucoside is found in herbs and spices.

   

4-(4-Hydroxyphenyl)-2-butanone glucoside

4-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)butan-2-one

C16H22O7 (326.1365)


4-(4-Hydroxyphenyl)-2-butanone glucoside is found in fruits. 4-(4-Hydroxyphenyl)-2-butanone glucoside is present in rhubarb and raspberrie Present in rhubarb and raspberries. 4-(4-Hydroxyphenyl)-2-butanone glucoside is found in fruits and green vegetables. Raspberry ketone glucoside is a natural product in raspberry fruit. Raspberry ketone glucosidev has the inhibitory effect on the melanin synthesis[1]. Raspberry ketone glucoside is a natural product in raspberry fruit. Raspberry ketone glucosidev has the inhibitory effect on the melanin synthesis[1].

   

Hydroxyhexamide

1-cyclohexyl-3-[4-(1-hydroxyethyl)benzenesulfonyl]urea

C15H22N2O4S (326.13)


Hydroxyhexamide is a metabolite of acetohexamide. Acetohexamide (trade name Dymelor) is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2, particularly in people whose diabetes cannot be controlled by diet alone. (Wikipedia)

   

N-(N-Acetylmethionyl)dopamine

N-[2-(3,4-Dihydroxyphenyl)ethyl]-2-[(1-hydroxyethylidene)amino]-4-(methylsulphanyl)butanimidic acid

C15H22N2O4S (326.13)


   

3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine

3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine

C18H19ClN4 (326.1298)


   

(2S,3S,4S,5R)-3,4,5-Trihydroxy-6-(5-methyl-2-propan-2-ylphenoxy)oxane-2-carboxylic acid

(2S,3S,4S,5R)-3,4,5-Trihydroxy-6-(5-methyl-2-propan-2-ylphenoxy)oxane-2-carboxylic acid

C16H22O7 (326.1365)


   

Nipradilol

8-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}-3,4-dihydro-2H-1-benzopyran-3-yl nitrate

C15H22N2O6 (326.1478)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Eugenyl glucoside

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-methoxy-4-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

C16H22O7 (326.1365)


Eugenyl glucoside, also known as eugenyl beta-D-glucopyranoside, is a member of the class of compounds known as phenolic glycosides. Phenolic glycosides are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. Eugenyl glucoside is soluble (in water) and a very weakly acidic compound (based on its pKa). Eugenyl glucoside can be found in lemon balm, which makes eugenyl glucoside a potential biomarker for the consumption of this food product.

   

Oristar RKG

(4-Hydroxyphenyl)-2-butanone beta-D-glucoside; 4-[4-(beta-D-Glucopyranosyloxy)phenyl]-2-butanone;Raspberry ketone glucoside

C16H22O7 (326.1365)


Raspberryketone glucoside is a natural product found in Rheum palmatum, Artemisia santolinifolia, and other organisms with data available. Raspberry ketone glucoside is a natural product in raspberry fruit. Raspberry ketone glucosidev has the inhibitory effect on the melanin synthesis[1]. Raspberry ketone glucoside is a natural product in raspberry fruit. Raspberry ketone glucosidev has the inhibitory effect on the melanin synthesis[1].

   

Spicatolide D

Spicatolide D

C16H22O7 (326.1365)


   

Spicatolide F

Spicatolide F

C16H22O7 (326.1365)


   

Bidensyneoside A1

Bidensyneoside A1

C16H22O7 (326.1365)


   
   

(+)-Macrosphelide C

(+)-Macrosphelide C

C16H22O7 (326.1365)


   

Oligandrumin E

Oligandrumin E

C16H22O7 (326.1365)


   

Tetradehydroreticuline

Tetradehydroreticuline

C19H20NO4 (326.1392)


   
   

Chavibetol glucoside

Chavibetol glucoside

C16H22O7 (326.1365)


   

MCULE-3393885085

MCULE-3393885085

C15H22N2O6 (326.1478)


   

Maybridge1_000875

Maybridge1_000875

C18H19ClN4 (326.1298)


   

clozapine

Clozapine (Clozaril)

C18H19ClN4 (326.1298)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AH - Diazepines, oxazepines, thiazepines and oxepines D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent CONFIDENCE standard compound; INTERNAL_ID 8610 CONFIDENCE standard compound; INTERNAL_ID 1600 Clozapine (HF 1854) is an antipsychotic used for the research of schizophrenia. Clozapine has high affinity for a number of neuroreceptors. Clozapine is a potent antagonist of dopamine D2 with a Ki of 75 nM. Clozapine inhibits the muscarinic M1 receptor and serotonin 5HT2A receptor with Kis of 9.5 nM and 4 nM, respectively[1][2][3]. Clozapine is also a potent and selective agonist at the muscarinic M4 receptor (EC50=11 nM)[4].

   

[(4E)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (E)-but-2-enoate

[(4E)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (E)-but-2-enoate

C16H22O7 (326.1365)


   

eugenyl beta-D-glucopyranoside|eugenylglucoside

eugenyl beta-D-glucopyranoside|eugenylglucoside

C16H22O7 (326.1365)


   

Di-Ac-Pavonisol

Di-Ac-Pavonisol

C16H22O7 (326.1365)


   

(E)-1-(2-hydroxy-5-methoxyphenyl)propene beta-D-glucopyranoside

(E)-1-(2-hydroxy-5-methoxyphenyl)propene beta-D-glucopyranoside

C16H22O7 (326.1365)


   

beta-D-glucosyl isoeugenol|isoeugenol beta-D-glucopyranoside|trans-isoeugenyl beta-glucoside

beta-D-glucosyl isoeugenol|isoeugenol beta-D-glucopyranoside|trans-isoeugenyl beta-glucoside

C16H22O7 (326.1365)


   
   

cupressotropolone A

cupressotropolone A

C16H22O7 (326.1365)


   

1,2-Diacetoxy-1-(2,4,5-trimethoxy-phenyl)-propan|1,2-diacetoxy-1-(2,4,5-trimethoxy-phenyl)-propane|1-(2,4,5-Trimethoxyphenyl)-1,2-diacetoxypropane|2,4,5,-Tri-Me ether,1,2-di-Ac-1-(2,4,5-Trihydroxyphenyl)-1,2-propanediol

1,2-Diacetoxy-1-(2,4,5-trimethoxy-phenyl)-propan|1,2-diacetoxy-1-(2,4,5-trimethoxy-phenyl)-propane|1-(2,4,5-Trimethoxyphenyl)-1,2-diacetoxypropane|2,4,5,-Tri-Me ether,1,2-di-Ac-1-(2,4,5-Trihydroxyphenyl)-1,2-propanediol

C16H22O7 (326.1365)


   

Hyrtioseragamine A

Hyrtioseragamine A

C16H18N6O2 (326.1491)


   

(E)-3-Hydroxyanethole ??-D-glucopyranoside

(E)-3-Hydroxyanethole ??-D-glucopyranoside

C16H22O7 (326.1365)


   

O1-((S)-1-phenyl-butyl)-beta-D-glucopyranuronic acid|O1-((S)-1-Phenyl-butyl)-beta-D-glucopyranuronsaeure

O1-((S)-1-phenyl-butyl)-beta-D-glucopyranuronic acid|O1-((S)-1-Phenyl-butyl)-beta-D-glucopyranuronsaeure

C16H22O7 (326.1365)


   

(3R,4R)-4,8-dihydroxy-6,7-dimethoxy-3-((R)-2-hydroxypentyl)isochroman-1-one|fusarentin

(3R,4R)-4,8-dihydroxy-6,7-dimethoxy-3-((R)-2-hydroxypentyl)isochroman-1-one|fusarentin

C16H22O7 (326.1365)


   

Neolymphostinol A

Neolymphostinol A

C17H18N4O3 (326.1379)


   
   

deca-9-en-4,6-diyne-1,8-diol 8-O-beta-D-glucopyranoside

deca-9-en-4,6-diyne-1,8-diol 8-O-beta-D-glucopyranoside

C16H22O7 (326.1365)


   

deca-9-en-4,6-diyne-1,8-diol 1-O-beta-D-glucopyranoside

deca-9-en-4,6-diyne-1,8-diol 1-O-beta-D-glucopyranoside

C16H22O7 (326.1365)


   
   
   

8-oxo-6-hydroxydihydrophaseic acid methyl ester

8-oxo-6-hydroxydihydrophaseic acid methyl ester

C16H22O7 (326.1365)


   

beta-D-glucopyranoside-4-phenylbutan-2-one

beta-D-glucopyranoside-4-phenylbutan-2-one

C16H22O7 (326.1365)


   

3-keto rhododendrin

3-keto rhododendrin

C16H22O7 (326.1365)


   

Trimethylsilyl [3-methoxy-4-(trimethylsilyloxy)phenyl]acetate

Trimethylsilyl [3-methoxy-4-(trimethylsilyloxy)phenyl]acetate

C15H26O4Si2 (326.137)


   

(E)-1-(2-Hydroxy-5-methoxyphenyl)propene ??-D-glucopyranoside

(E)-1-(2-Hydroxy-5-methoxyphenyl)propene ??-D-glucopyranoside

C16H22O7 (326.1365)


   

N1=CC2=CC(C(=O)CCO)=NC3=C2C1=C(N)C=C3NC(=O)CCC

N1=CC2=CC(C(=O)CCO)=NC3=C2C1=C(N)C=C3NC(=O)CCC

C17H18N4O3 (326.1379)


   

(+)-macrosphelide G|macrosphelide G

(+)-macrosphelide G|macrosphelide G

C16H22O7 (326.1365)


   

3-Deoxybidensyneoside B|3-deoxybidensyneoside C|8(E)-8-decene-4,6-diyne-1,10-diol 1-O-beta-D-glucopyranoside

3-Deoxybidensyneoside B|3-deoxybidensyneoside C|8(E)-8-decene-4,6-diyne-1,10-diol 1-O-beta-D-glucopyranoside

C16H22O7 (326.1365)


   

boletunone A

boletunone A

C16H22O7 (326.1365)


   

(2S,3S,5S,Z)-5-hydroxy-7-((R)-6-oxo-3,6-dihydro-2H-pyran-2-yl)hept-6-ene-2,3-diyl diacetate|synparvolide B

(2S,3S,5S,Z)-5-hydroxy-7-((R)-6-oxo-3,6-dihydro-2H-pyran-2-yl)hept-6-ene-2,3-diyl diacetate|synparvolide B

C16H22O7 (326.1365)


   
   
   
   
   
   

ACEPROMAZINE

Acepromazine (oxide)

C19H22N2OS (326.1453)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

4-amino-2-hydroxy-5-[[1-hydroxy-1-(5-oxo-6-bicyclo[4.1.0]hept-3-enyl)propan-2-yl]amino]-5-oxopentanoic acid

NCGC00347558-02!4-amino-2-hydroxy-5-[[1-hydroxy-1-(5-oxo-6-bicyclo[4.1.0]hept-3-enyl)propan-2-yl]amino]-5-oxopentanoic acid

C15H22N2O6 (326.1478)


   

C16H22O7_(4E)-7-Acetoxy-6-hydroxy-2-methyl-10-oxo-3,6,7,8,9,10-hexahydro-2H-oxecin-3-yl (2E)-2-butenoate

NCGC00380409-01_C16H22O7_(4E)-7-Acetoxy-6-hydroxy-2-methyl-10-oxo-3,6,7,8,9,10-hexahydro-2H-oxecin-3-yl (2E)-2-butenoate

C16H22O7 (326.1365)


   

4-amino-2-hydroxy-5-[[1-hydroxy-1-(5-oxo-6-bicyclo[4.1.0]hept-3-enyl)propan-2-yl]amino]-5-oxopentanoic acid

4-amino-2-hydroxy-5-[[1-hydroxy-1-(5-oxo-6-bicyclo[4.1.0]hept-3-enyl)propan-2-yl]amino]-5-oxopentanoic acid

C15H22N2O6 (326.1478)


   

Aceprometazine

10-(2-(Dimethylamino)propyl)phenothiazin-2-yl methyl ketone;Aceprometazina [inn-spanish];Aceprometazinum [inn-latin];Acepromethazine

C19H22N2OS (326.1453)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

4-amino-2-hydroxy-5-[[1-hydroxy-1-(5-oxo-6-bicyclo[4.1.0]hept-3-enyl)propan-2-yl]amino]-5-oxopentanoic acid_major

4-amino-2-hydroxy-5-[[1-hydroxy-1-(5-oxo-6-bicyclo[4.1.0]hept-3-enyl)propan-2-yl]amino]-5-oxopentanoic acid_major

C15H22N2O6 (326.1478)


   

4-amino-2-hydroxy-5-[[1-hydroxy-1-(5-oxo-6-bicyclo[4.1.0]hept-3-enyl)propan-2-yl]amino]-5-oxopentanoic acid_95.8\\%

4-amino-2-hydroxy-5-[[1-hydroxy-1-(5-oxo-6-bicyclo[4.1.0]hept-3-enyl)propan-2-yl]amino]-5-oxopentanoic acid_95.8\\%

C15H22N2O6 (326.1478)


   

[(4E)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (E)-but-2-enoate_major

[(4E)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (E)-but-2-enoate_major

C16H22O7 (326.1365)


   

[(4E)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (E)-but-2-enoate_61.4\\%

[(4E)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (E)-but-2-enoate_61.4\\%

C16H22O7 (326.1365)


   

[(4E)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (E)-but-2-enoate_59.2\\%

[(4E)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (E)-but-2-enoate_59.2\\%

C16H22O7 (326.1365)


   

Gly Gly Gly His

(2S)-2-{2-[2-(2-aminoacetamido)acetamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C12H18N6O5 (326.1339)


   

Gly Gly His Gly

2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C12H18N6O5 (326.1339)


   

Gly His Gly Gly

2-{2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]acetamido}acetic acid

C12H18N6O5 (326.1339)


   

His Gly Gly Gly

2-(2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}acetamido)acetic acid

C12H18N6O5 (326.1339)


   
   

PGE-mum

8-[(1R,2R,5R)-2-(2-carboxyethyl)-5-hydroxy-3-oxocyclopentyl]-6-oxooctanoic acid

C16H22O7 (326.1365)


   

Acetylpromazine

1-{10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethan-1-one

C19H22N2OS (326.1453)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

1-Methoxy-3-(4-hydroxyphenyl)-2E-propenal 4'-glucoside

2-(hydroxymethyl)-6-{4-[(1E)-3-methoxyprop-1-en-1-yl]phenoxy}oxane-3,4,5-triol

C16H22O7 (326.1365)


   

Raspberry ketone glucoside

4-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)butan-2-one

C16H22O7 (326.1365)


Raspberry ketone glucoside is a natural product in raspberry fruit. Raspberry ketone glucosidev has the inhibitory effect on the melanin synthesis[1]. Raspberry ketone glucoside is a natural product in raspberry fruit. Raspberry ketone glucosidev has the inhibitory effect on the melanin synthesis[1].

   

Citrusin C

2-(hydroxymethyl)-6-[2-methoxy-4-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

C16H22O7 (326.1365)


   

citrusin

4-Allyl-2-methoxyphenyl ?-D-glucopyranoside

C16H22O7 (326.1365)


   

(4E)-7-Acetoxy-6-hydroxy-2-methyl-10-oxo-3,6,7,8,9,10-hexahydro-2H-oxecin-3-yl (2E)-2-butenoate

(4E)-7-Acetoxy-6-hydroxy-2-methyl-10-oxo-3,6,7,8,9,10-hexahydro-2H-oxecin-3-yl (2E)-2-butenoate

C16H22O7 (326.1365)


   

aspirin DL-lysine salt

aspirin DL-lysine salt

C15H22N2O6 (326.1478)


   

2-(2-Methoxyphenyl)-4,5-diphenyl-1H-imidazole

2-(2-Methoxyphenyl)-4,5-diphenyl-1H-imidazole

C22H18N2O (326.1419)


   

N-(2-Amino-1,1-binaphthalen-3-yl)acetamide

N-(2-Amino-1,1-binaphthalen-3-yl)acetamide

C22H18N2O (326.1419)


   

4-(BROMOMETHYL)BENZENESULFONYLCHLORIDE

4-(BROMOMETHYL)BENZENESULFONYLCHLORIDE

C15H22N2O4S (326.13)


   

(3-METHYL-PYRIDIN-2-YL)-HYDRAZINE

(3-METHYL-PYRIDIN-2-YL)-HYDRAZINE

C15H22N2O4S (326.13)


   

2-trimethylsiloxy-4-allyloxydiphenylketone

2-trimethylsiloxy-4-allyloxydiphenylketone

C19H22O3Si (326.1338)


   

N-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)PROPANE-2-SULFONAMIDE

N-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)PROPANE-2-SULFONAMIDE

C14H23BN2O4S (326.1472)


   

4-METHYL-2-[1-(TERT-BUTOXYCARBONYL)PIPERID-4-YL]-1,3-THIAZOLE-5-CARBOXYLIC ACID

4-METHYL-2-[1-(TERT-BUTOXYCARBONYL)PIPERID-4-YL]-1,3-THIAZOLE-5-CARBOXYLIC ACID

C15H22N2O4S (326.13)


   

4-Methoxyphenyl 3-O-Allyl-β-D-galactopyranoside

4-Methoxyphenyl 3-O-Allyl-β-D-galactopyranoside

C16H22O7 (326.1365)


   

4-methoxyphenyl 3,4-o-isopropylidene-beta-d-galactopyranoside

4-methoxyphenyl 3,4-o-isopropylidene-beta-d-galactopyranoside

C16H22O7 (326.1365)


   

Meptin

Procaterol hydrochloride

C16H23ClN2O3 (326.1397)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

   

4-Chloro-5-fluoro-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine

4-Chloro-5-fluoro-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine

C16H24ClFN2Si (326.1381)


   

Dicyclohexylboron Triflate

Dicyclohexylboron Triflate

C13H22BF3O3S (326.1335)


   

1-(2-FLUOROPHENYL)BIGUANIDEHYDROCHLORIDE

1-(2-FLUOROPHENYL)BIGUANIDEHYDROCHLORIDE

C17H18N4O3 (326.1379)


   

[7-(4-METHYLPIPERAZIN-1-YL)THIAZOLO[5,4-D]PYRIMIDIN-2-YL]PHENYLAMINE

[7-(4-METHYLPIPERAZIN-1-YL)THIAZOLO[5,4-D]PYRIMIDIN-2-YL]PHENYLAMINE

C16H18N6S (326.1314)


   

L-745870

3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine

C18H19ClN4 (326.1298)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants L-745870 is a potent, selective, brain-penetrant and orally active dopamine D4 receptor antagonist with a Ki of 0.43 nM. L-745870 shows weaker affinity for D2 (Ki of 960 nM) and D3 (Ki of 2300 nM) receptors, and exhibits moderate affinity for 5-HT2 receptors, sigma sites and α-adrenoceptors[1][2][3].

   

METHYL 4-(PHENYL-PROPIONYL-AMINO)-PIPERIDINE-4-CARBOXYLATE HCL

METHYL 4-(PHENYL-PROPIONYL-AMINO)-PIPERIDINE-4-CARBOXYLATE HCL

C16H23ClN2O3 (326.1397)


   

ethyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,prop-2-enenitrile,prop-2-enoic acid

ethyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,prop-2-enenitrile,prop-2-enoic acid

C15H22N2O6 (326.1478)


   

4-Benzenesulfonyl-piperazine-1-carboxylic acid tert-butyl ester

4-Benzenesulfonyl-piperazine-1-carboxylic acid tert-butyl ester

C15H22N2O4S (326.13)


   

2-(1H-IMIDAZOL-1-YLDIPHENYLMETHYL)-PHENOL

2-(1H-IMIDAZOL-1-YLDIPHENYLMETHYL)-PHENOL

C22H18N2O (326.1419)


   

10-(a-diethylaminopropionyl)-phenothiazi ne hydrochloride (as-139

10-(a-diethylaminopropionyl)-phenothiazi ne hydrochloride (as-139

C19H22N2OS (326.1453)


   

DIETHYL 3,4,5-TRIMETHOXYPHENYL MALONATE

DIETHYL 3,4,5-TRIMETHOXYPHENYL MALONATE

C16H22O7 (326.1365)


   

1,3-DIPHENYL-5-(4-METHOXYPHENYL)-1H-PYRAZOLE

1,3-DIPHENYL-5-(4-METHOXYPHENYL)-1H-PYRAZOLE

C22H18N2O (326.1419)


   

4-Methoxycarbonylbenzo-15-crown 5-Ether

4-Methoxycarbonylbenzo-15-crown 5-Ether

C16H22O7 (326.1365)


   

Glycine,N,N-1,2-ethanediylbis[N-(carboxymethyl)-, ammonium salt (1:2)

Glycine,N,N-1,2-ethanediylbis[N-(carboxymethyl)-, ammonium salt (1:2)

C10H22N4O8 (326.1438)


   

1H-Pyrazole,3-(4-methoxyphenyl)-1,5-diphenyl-

1H-Pyrazole,3-(4-methoxyphenyl)-1,5-diphenyl-

C22H18N2O (326.1419)


   

2-(Boc-Amino)thiazole-5-boronic acid pinacol ester

2-(Boc-Amino)thiazole-5-boronic acid pinacol ester

C14H23BN2O4S (326.1472)


   

2-Amino-4,7-dihydro-5H-thieno[2,3-c]pyridine-3,6-dicarboxylic acid 6-tert-butyl ester 3-ethyl ester

2-Amino-4,7-dihydro-5H-thieno[2,3-c]pyridine-3,6-dicarboxylic acid 6-tert-butyl ester 3-ethyl ester

C15H22N2O4S (326.13)


   

N1,N3-Dibenzylpropane-1,3-diamine dihydrochloride

N1,N3-Dibenzylpropane-1,3-diamine dihydrochloride

C17H24Cl2N2 (326.1316)


   

1-Boc-4-(carboxy-thiophen-2-yl-methyl)-piperazine

1-Boc-4-(carboxy-thiophen-2-yl-methyl)-piperazine

C15H22N2O4S (326.13)


   

8-(2-methoxy-2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one,hydrochloride

8-(2-methoxy-2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one,hydrochloride

C16H23ClN2O3 (326.1397)


   

N-(3-Amino-1,1-binaphthalen-2-yl)acetamide

N-(3-Amino-1,1-binaphthalen-2-yl)acetamide

C22H18N2O (326.1419)


   

1-hexyl-2,3-dimethylimidazolium hexafluorophosphate

1-hexyl-2,3-dimethylimidazolium hexafluorophosphate

C11H21F6N2P (326.1346)


   

2-(4-BOC-PIPERAZINYL)-2-(3-THIENYL)ACETIC ACID

2-(4-BOC-PIPERAZINYL)-2-(3-THIENYL)ACETIC ACID

C15H22N2O4S (326.13)


   

4-(3,5-Diphenyl-4,5-dihydro-1H-pyrazol-1-yl)benzaldehyde

4-(3,5-Diphenyl-4,5-dihydro-1H-pyrazol-1-yl)benzaldehyde

C22H18N2O (326.1419)


   

Tiazesim

Tiazesim

C19H22N2OS (326.1453)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

4,9-dimethyl-3-(2H-tetrazol-5-ylmethoxy)-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-6-one

4,9-dimethyl-3-(2H-tetrazol-5-ylmethoxy)-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-6-one

C17H18N4O3 (326.1379)


   

Aceprometazine, (R)-

Aceprometazine, (R)-

C19H22N2OS (326.1453)


   

(2-Hydroxy-3-phosphonooxypropyl) decanoate

(2-Hydroxy-3-phosphonooxypropyl) decanoate

C13H27O7P (326.1494)


   

5,5-Diethoxy-4-hydroxy-2-oxopentylphosphonic acid diethyl ester

5,5-Diethoxy-4-hydroxy-2-oxopentylphosphonic acid diethyl ester

C13H27O7P (326.1494)


   

4-(6-{[(1r)-1-(Hydroxymethyl)propyl]amino}imidazo[1,2-B]pyridazin-3-Yl)benzoic Acid

4-(6-{[(1r)-1-(Hydroxymethyl)propyl]amino}imidazo[1,2-B]pyridazin-3-Yl)benzoic Acid

C17H18N4O3 (326.1379)


   

Nipradilol

Nipradilol

C15H22N2O6 (326.1478)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Lysine acetylsalicylate

Lysine acetylsalicylate

C15H22N2O6 (326.1478)


D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D004791 - Enzyme Inhibitors

   

4-Amino-2-hydroxy-5-[[1-hydroxy-1-(2-oxo-1-bicyclo[4.1.0]hept-3-enyl)propan-2-yl]amino]-5-oxopentanoic acid

4-Amino-2-hydroxy-5-[[1-hydroxy-1-(2-oxo-1-bicyclo[4.1.0]hept-3-enyl)propan-2-yl]amino]-5-oxopentanoic acid

C15H22N2O6 (326.1478)


   

(S)-Bulbocapnine

(S)-Bulbocapnine

C19H20NO4+ (326.1392)


   

scoulerine intermediate I

scoulerine intermediate I

C19H20NO4+ (326.1392)


   

scoulerine intermediate II

scoulerine intermediate II

C19H20NO4+ (326.1392)


   

3-[2-(4-methyl-2-propan-2-ylphenoxy)ethyl]-1H-benzimidazole-2-thione

3-[2-(4-methyl-2-propan-2-ylphenoxy)ethyl]-1H-benzimidazole-2-thione

C19H22N2OS (326.1453)


   

3-Piperidin-1-ylpropyl 4-amino-5-chloro-2-methoxybenzoate

3-Piperidin-1-ylpropyl 4-amino-5-chloro-2-methoxybenzoate

C16H23ClN2O3 (326.1397)


   

(3R,4R)-4,8-dihydroxy-3-((R)-2-hydroxypentyl)-6,7-dimethoxyisochroman-1-one

(3R,4R)-4,8-dihydroxy-3-((R)-2-hydroxypentyl)-6,7-dimethoxyisochroman-1-one

C16H22O7 (326.1365)


A natural product found in Colletotrichum species.

   

[4-(2-Hydroxyethyl)-1-piperazinyl]-(4-phenylphenyl)methanethione

[4-(2-Hydroxyethyl)-1-piperazinyl]-(4-phenylphenyl)methanethione

C19H22N2OS (326.1453)


   

3-(4-Acetylphenyl)-1-(phenylmethyl)-1-propylthiourea

3-(4-Acetylphenyl)-1-(phenylmethyl)-1-propylthiourea

C19H22N2OS (326.1453)


   

1-Decanoyl-sn-glycero-3-phosphate

1-Decanoyl-sn-glycero-3-phosphate

C13H27O7P (326.1494)


A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as decanoyl.

   

N(2),N(2),7-trimethylguanosine

N(2),N(2),7-trimethylguanosine

C13H20N5O5+ (326.1464)


   
   
   
   

1,9,10-Trihydroxy-2-methoxy-6,6-dimethyl-5,6-dihydro-4H-dibenzo[de,g]quinoline-6-ium

1,9,10-Trihydroxy-2-methoxy-6,6-dimethyl-5,6-dihydro-4H-dibenzo[de,g]quinoline-6-ium

C19H20NO4+ (326.1392)


   

[(1R,2aS,8bS)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(4-fluorophenyl)methanone

[(1R,2aS,8bS)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(4-fluorophenyl)methanone

C19H19FN2O2 (326.143)


   

(6R,7S,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H19FN2O2 (326.143)


   

[(1S,2aR,8bR)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(4-fluorophenyl)methanone

[(1S,2aR,8bR)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(4-fluorophenyl)methanone

C19H19FN2O2 (326.143)


   

(6S,7S,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H19FN2O2 (326.143)


   

(6R,7S,8R)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8R)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H19FN2O2 (326.143)


   

(6S,7R,8R)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H19FN2O2 (326.143)


   

(6S,7R,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H19FN2O2 (326.143)


   

(6R,7R,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H19FN2O2 (326.143)


   

(S)-aceprometazine

(S)-aceprometazine

C19H22N2OS (326.1453)


   
   
   
   
   

2-[(Z)-1-(1-benzofuran-2-yl)prop-1-en-2-yl]-2,3-dihydro-1H-perimidine

2-[(Z)-1-(1-benzofuran-2-yl)prop-1-en-2-yl]-2,3-dihydro-1H-perimidine

C22H18N2O (326.1419)


   

2-(5-amino-4-cyano-1H-imidazol-1-yl)-5-(4-methylpiperazin-1-yl)benzoic acid

2-(5-amino-4-cyano-1H-imidazol-1-yl)-5-(4-methylpiperazin-1-yl)benzoic acid

C16H18N6O2 (326.1491)


   

3,4,5-Trihydroxy-6-(2-methyl-3-phenylpropoxy)oxane-2-carboxylic acid

3,4,5-Trihydroxy-6-(2-methyl-3-phenylpropoxy)oxane-2-carboxylic acid

C16H22O7 (326.1365)


   

(2Z,3Z)-2-hydroxyimino-3-[(4-methoxyphenyl)hydrazinylidene]-N-phenylbutanamide

(2Z,3Z)-2-hydroxyimino-3-[(4-methoxyphenyl)hydrazinylidene]-N-phenylbutanamide

C17H18N4O3 (326.1379)


   

2-[2,3-Diacetyloxypropoxy(hydroxy)phosphoryl]ethyl-trimethylazanium

2-[2,3-Diacetyloxypropoxy(hydroxy)phosphoryl]ethyl-trimethylazanium

C12H25NO7P+ (326.1369)


   

9,9-Bis(trimethylsilyl)-9-silafluorene

9,9-Bis(trimethylsilyl)-9-silafluorene

C18H26Si3 (326.1342)


   

2-(3-Benzoylphenyl)propionic acid trimethylsilyl ester

2-(3-Benzoylphenyl)propionic acid trimethylsilyl ester

C19H22O3Si (326.1338)


   

Dibenzo(D,F)-1,1,2,2,3,3-hexamethyl-1,2,3-trisilacyclohepta-4,6-diene

Dibenzo(D,F)-1,1,2,2,3,3-hexamethyl-1,2,3-trisilacyclohepta-4,6-diene

C18H26Si3 (326.1342)


   

Hydroxyhexamide

Hydroxyhexamide

C15H22N2O4S (326.13)


   

4-(4-Hydroxyphenyl)-2-butanone glucoside

4-(4-Hydroxyphenyl)-2-butanone glucoside

C16H22O7 (326.1365)


   

1-Methoxy-3-(4-hydroxyphenyl)-2E-propenal 4-glucoside

1-Methoxy-3-(4-hydroxyphenyl)-2E-propenal 4-glucoside

C16H22O7 (326.1365)


   

bulbocapnine(1+)

bulbocapnine(1+)

C19H20NO4 (326.1392)


An organic cation that is the conjugate acid of bulbocapnine, obtained by protonation of the tertiary amino group; major species at pH 7.3.

   
   

FAUC 213

FAUC 213

C18H19ClN4 (326.1298)


FAUC 213 is an orally active and highly selective dopamine D4 receptor complete antagonist with a Ki of 2.2 nM for hD4.4. FAUC 213 has less activity on D2 and D3 receptors (Kis of 3.4 μM, 5.3 μM for hD2, hD3, respectively). FAUC 213 can cross the blood-brain barrier (BBB). FAUC 213 exhibits atypical antipsychotic characteristic[1].

   

6-isopropyl-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohepta-2,4,6-trien-1-one

6-isopropyl-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohepta-2,4,6-trien-1-one

C16H22O7 (326.1365)


   

(4r,7e,9r,10s,13e,16s)-9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

(4r,7e,9r,10s,13e,16s)-9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

C16H22O7 (326.1365)


   

(1r,12s)-16-hydroxy-15-methoxy-1-methyl-5,7-dioxa-1-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13(18),14,16-hexaen-1-ium

(1r,12s)-16-hydroxy-15-methoxy-1-methyl-5,7-dioxa-1-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13(18),14,16-hexaen-1-ium

[C19H20NO4]+ (326.1392)


   

(12s)-15-hydroxy-16-methoxy-1-methyl-5,7-dioxa-1-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13(18),14,16-hexaen-1-ium

(12s)-15-hydroxy-16-methoxy-1-methyl-5,7-dioxa-1-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13(18),14,16-hexaen-1-ium

[C19H20NO4]+ (326.1392)


   

(4s,7e,10s,13e,15r,16s)-15-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

(4s,7e,10s,13e,15r,16s)-15-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

C16H22O7 (326.1365)


   

(6r,8s,9s,9as,9br)-6,9-dihydroxy-3-(hydroxymethyl)-9-methyl-2-oxo-4h,5h,5ah,6h,7h,8h,9ah,9bh-naphtho[1,2-b]furan-8-yl acetate

(6r,8s,9s,9as,9br)-6,9-dihydroxy-3-(hydroxymethyl)-9-methyl-2-oxo-4h,5h,5ah,6h,7h,8h,9ah,9bh-naphtho[1,2-b]furan-8-yl acetate

C16H22O7 (326.1365)


   

2-(acetyloxy)-5-hydroxy-7-(6-oxo-2,3-dihydropyran-2-yl)hept-6-en-3-yl acetate

2-(acetyloxy)-5-hydroxy-7-(6-oxo-2,3-dihydropyran-2-yl)hept-6-en-3-yl acetate

C16H22O7 (326.1365)


   

4-hydroxy-3-[4-hydroxy-1-(4-hydroxy-5-methyl-2-oxo-5h-furan-3-yl)hexyl]-5-methyl-5h-furan-2-one

4-hydroxy-3-[4-hydroxy-1-(4-hydroxy-5-methyl-2-oxo-5h-furan-3-yl)hexyl]-5-methyl-5h-furan-2-one

C16H22O7 (326.1365)


   

(2r,3r,4s,5s,6r)-2-{[(3s,8e)-3-hydroxydec-8-en-4,6-diyn-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s,8e)-3-hydroxydec-8-en-4,6-diyn-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H22O7 (326.1365)


   

15-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

15-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

C16H22O7 (326.1365)


   

(2s,3s,4as,6r,7s,8s,8as)-6-(hydroxymethyl)-2-(4-methoxyphenyl)-3-methyl-hexahydro-2h-pyrano[2,3-b][1,4]dioxine-7,8-diol

(2s,3s,4as,6r,7s,8s,8as)-6-(hydroxymethyl)-2-(4-methoxyphenyl)-3-methyl-hexahydro-2h-pyrano[2,3-b][1,4]dioxine-7,8-diol

C16H22O7 (326.1365)


   

(4r,7z,10s,13z,15r,16s)-15-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

(4r,7z,10s,13z,15r,16s)-15-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

C16H22O7 (326.1365)


   

3-[3-(7-butyl-6-hydroxy-4-methyl-6,7-dihydro-1,5,2,3-dioxadiazepin-2-yl)-3-oxopropyl]-5h-furan-2-one

3-[3-(7-butyl-6-hydroxy-4-methyl-6,7-dihydro-1,5,2,3-dioxadiazepin-2-yl)-3-oxopropyl]-5h-furan-2-one

C15H22N2O6 (326.1478)


   

2-[(3-hydroxydec-8-en-4,6-diyn-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(3-hydroxydec-8-en-4,6-diyn-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C16H22O7 (326.1365)


   

16-hydroxy-15-methoxy-1-methyl-5,7-dioxa-1-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13(18),14,16-hexaen-1-ium

16-hydroxy-15-methoxy-1-methyl-5,7-dioxa-1-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13(18),14,16-hexaen-1-ium

[C19H20NO4]+ (326.1392)


   

1-(acetyloxy)-1-(2,4,5-trimethoxyphenyl)propan-2-yl acetate

1-(acetyloxy)-1-(2,4,5-trimethoxyphenyl)propan-2-yl acetate

C16H22O7 (326.1365)


   

3-deoxybidensyneoside b

NA

C16H22O7 (326.1365)


{"Ingredient_id": "HBIN008430","Ingredient_name": "3-deoxybidensyneoside b","Alias": "NA","Ingredient_formula": "C16H22O7","Ingredient_Smile": "C(CC#CC#CC=CCO)COC1C(C(C(C(O1)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5154","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

bidensyneoside a1

NA

C16H22O7 (326.1365)


{"Ingredient_id": "HBIN018478","Ingredient_name": "bidensyneoside a1","Alias": "NA","Ingredient_formula": "C16H22O7","Ingredient_Smile": "CC=CC#CC#CC(CCOC1C(C(C(C(O1)CO)O)O)O)O","Ingredient_weight": "326.34 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2359","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10903496","DrugBank_id": "NA"}

   

bidensyneoside a2

NA

C16H22O7 (326.1365)


{"Ingredient_id": "HBIN018479","Ingredient_name": "bidensyneoside a2","Alias": "NA","Ingredient_formula": "C16H22O7","Ingredient_Smile": "C(CC#CC#CC=CCO)COC1C(C(C(C(O1)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2360","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

ethyl (2r,4s)-4-(3-acetyl-2,6-dihydroxyphenyl)-2,4-dimethoxybutanoate

ethyl (2r,4s)-4-(3-acetyl-2,6-dihydroxyphenyl)-2,4-dimethoxybutanoate

C16H22O7 (326.1365)


   

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{2-methoxy-4-[(1e)-prop-1-en-1-yl]phenoxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{2-methoxy-4-[(1e)-prop-1-en-1-yl]phenoxy}oxane-3,4,5-triol

C16H22O7 (326.1365)


   

(4r,7z,9r,10s,13z,16s)-9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

(4r,7z,9r,10s,13z,16s)-9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

C16H22O7 (326.1365)


   

(2r,3r,4s,5s,6r)-2-{[(3r,8z)-3-hydroxydec-8-en-4,6-diyn-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3r,8z)-3-hydroxydec-8-en-4,6-diyn-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H22O7 (326.1365)


   

2-(hydroxymethyl)-6-{[3-(4-methoxyphenyl)prop-2-en-1-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[3-(4-methoxyphenyl)prop-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H22O7 (326.1365)


   

(1s,3r,7r,8s,9s,10r)-1,9-dihydroxy-13-(methoxymethyl)-7,10-dimethyl-2,5-dioxatricyclo[8.4.0.0³,⁸]tetradec-12-ene-4,14-dione

(1s,3r,7r,8s,9s,10r)-1,9-dihydroxy-13-(methoxymethyl)-7,10-dimethyl-2,5-dioxatricyclo[8.4.0.0³,⁸]tetradec-12-ene-4,14-dione

C16H22O7 (326.1365)


   

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{4-[(1e)-3-methoxyprop-1-en-1-yl]phenoxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{4-[(1e)-3-methoxyprop-1-en-1-yl]phenoxy}oxane-3,4,5-triol

C16H22O7 (326.1365)


   

(12r)-15-hydroxy-16-methoxy-1-methyl-5,7-dioxa-1-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13(18),14,16-hexaen-1-ium

(12r)-15-hydroxy-16-methoxy-1-methyl-5,7-dioxa-1-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13(18),14,16-hexaen-1-ium

[C19H20NO4]+ (326.1392)


   

9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

9-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

C16H22O7 (326.1365)


   

methyl (2r,4r)-4-(3-acetyl-2,6-dihydroxyphenyl)-4-ethoxy-2-methoxybutanoate

methyl (2r,4r)-4-(3-acetyl-2,6-dihydroxyphenyl)-4-ethoxy-2-methoxybutanoate

C16H22O7 (326.1365)


   

(1r,2e,8s,10r,11s)-8,10,11-trihydroxy-6-(methoxymethyl)-1,10-dimethyl-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-5-one

(1r,2e,8s,10r,11s)-8,10,11-trihydroxy-6-(methoxymethyl)-1,10-dimethyl-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-5-one

C16H22O7 (326.1365)


   

2-[(10-hydroxydec-8-en-4,6-diyn-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(10-hydroxydec-8-en-4,6-diyn-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C16H22O7 (326.1365)


   

n-[6-(3-hydroxypropanoyl)-11-imino-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,5,8(12),9-pentaen-9-yl]-2-methylpropanimidic acid

n-[6-(3-hydroxypropanoyl)-11-imino-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,5,8(12),9-pentaen-9-yl]-2-methylpropanimidic acid

C17H18N4O3 (326.1379)


   

(1r,12s)-15-hydroxy-16-methoxy-1-methyl-5,7-dioxa-1-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13(18),14,16-hexaen-1-ium

(1r,12s)-15-hydroxy-16-methoxy-1-methyl-5,7-dioxa-1-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13(18),14,16-hexaen-1-ium

[C19H20NO4]+ (326.1392)


   

(12s)-16-hydroxy-15-methoxy-1-methyl-5,7-dioxa-1-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13(18),14,16-hexaen-1-ium

(12s)-16-hydroxy-15-methoxy-1-methyl-5,7-dioxa-1-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-2,4(8),9,13(18),14,16-hexaen-1-ium

[C19H20NO4]+ (326.1392)


   

4,5,16-trihydroxy-15-methoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaen-10-ium

4,5,16-trihydroxy-15-methoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaen-10-ium

[C19H20NO4]+ (326.1392)


   

2-(hydroxymethyl)-6-[3-methoxy-4-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[3-methoxy-4-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

C16H22O7 (326.1365)


   

2-(hydroxymethyl)-6-[2-methoxy-5-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[2-methoxy-5-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

C16H22O7 (326.1365)


   

(2r,3r,4s,5s,6r)-2-{[(8e)-10-hydroxydec-8-en-4,6-diyn-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(8e)-10-hydroxydec-8-en-4,6-diyn-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H22O7 (326.1365)


   

(2r,3s,4r,5r,6s)-2-(hydroxymethyl)-6-[3-methoxy-4-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

(2r,3s,4r,5r,6s)-2-(hydroxymethyl)-6-[3-methoxy-4-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

C16H22O7 (326.1365)


   

(2s,3s,5s,6e)-2-(acetyloxy)-5-hydroxy-7-[(2r)-6-oxo-2,3-dihydropyran-2-yl]hept-6-en-3-yl acetate

(2s,3s,5s,6e)-2-(acetyloxy)-5-hydroxy-7-[(2r)-6-oxo-2,3-dihydropyran-2-yl]hept-6-en-3-yl acetate

C16H22O7 (326.1365)


   

(2r,3r,4s,5s,6r)-2-{[(3r,8e)-3-hydroxydec-8-en-4,6-diyn-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3r,8e)-3-hydroxydec-8-en-4,6-diyn-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H22O7 (326.1365)


   

6,12-dihydroxy-4-(methoxymethyl)-8,12-dimethyl-2,14-dioxatricyclo[6.5.1.0¹,⁵]tetradec-4-ene-3,9-dione

6,12-dihydroxy-4-(methoxymethyl)-8,12-dimethyl-2,14-dioxatricyclo[6.5.1.0¹,⁵]tetradec-4-ene-3,9-dione

C16H22O7 (326.1365)


   

(4r,7e,10s,13e,15r,16s)-15-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

(4r,7e,10s,13e,15r,16s)-15-hydroxy-4,10,16-trimethyl-1,5,11-trioxacyclohexadeca-7,13-diene-2,6,12-trione

C16H22O7 (326.1365)


   

(2s,3r,4r,5s,6r)-2-(hydroxymethyl)-6-({[(2z)-3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}methyl)oxane-3,4,5-triol

(2s,3r,4r,5s,6r)-2-(hydroxymethyl)-6-({[(2z)-3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}methyl)oxane-3,4,5-triol

C16H22O7 (326.1365)


   

(3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(2e)-3-(4-methoxyphenyl)prop-2-en-1-yl]oxy}oxane-3,4,5-triol

(3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(2e)-3-(4-methoxyphenyl)prop-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H22O7 (326.1365)


   

4,8-dihydroxy-3-(2-hydroxypentyl)-6,7-dimethoxy-3,4-dihydro-2-benzopyran-1-one

4,8-dihydroxy-3-(2-hydroxypentyl)-6,7-dimethoxy-3,4-dihydro-2-benzopyran-1-one

C16H22O7 (326.1365)


   

1-(3,4-dihydroxy-5,7,8-trimethoxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)ethanone

1-(3,4-dihydroxy-5,7,8-trimethoxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)ethanone

C16H22O7 (326.1365)


   

(2s,3s,5s,6z)-2-(acetyloxy)-5-hydroxy-7-[(2r)-6-oxo-2,3-dihydropyran-2-yl]hept-6-en-3-yl acetate

(2s,3s,5s,6z)-2-(acetyloxy)-5-hydroxy-7-[(2r)-6-oxo-2,3-dihydropyran-2-yl]hept-6-en-3-yl acetate

C16H22O7 (326.1365)


   

3-{3-[(6r,7r)-7-butyl-6-hydroxy-4-methyl-6,7-dihydro-1,5,2,3-dioxadiazepin-2-yl]-3-oxopropyl}-5h-furan-2-one

3-{3-[(6r,7r)-7-butyl-6-hydroxy-4-methyl-6,7-dihydro-1,5,2,3-dioxadiazepin-2-yl]-3-oxopropyl}-5h-furan-2-one

C15H22N2O6 (326.1478)


   

(1s,6s,8r,12r)-6,12-dihydroxy-4-(methoxymethyl)-8,12-dimethyl-2,14-dioxatricyclo[6.5.1.0¹,⁵]tetradec-4-ene-3,9-dione

(1s,6s,8r,12r)-6,12-dihydroxy-4-(methoxymethyl)-8,12-dimethyl-2,14-dioxatricyclo[6.5.1.0¹,⁵]tetradec-4-ene-3,9-dione

C16H22O7 (326.1365)


   

4-(4-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)butan-2-one

4-(4-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)butan-2-one

C16H22O7 (326.1365)


   

2-(hydroxymethyl)-6-({[3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}methyl)oxane-3,4,5-triol

2-(hydroxymethyl)-6-({[3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}methyl)oxane-3,4,5-triol

C16H22O7 (326.1365)


   

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[2-methoxy-5-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[2-methoxy-5-(prop-2-en-1-yl)phenoxy]oxane-3,4,5-triol

C16H22O7 (326.1365)


   

7-(acetyloxy)-6-hydroxy-2-methyl-10-oxo-2,5,6,7,8,9-hexahydrooxecin-5-yl but-2-enoate

7-(acetyloxy)-6-hydroxy-2-methyl-10-oxo-2,5,6,7,8,9-hexahydrooxecin-5-yl but-2-enoate

C16H22O7 (326.1365)


   

6-isopropyl-2-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohepta-2,4,6-trien-1-one

6-isopropyl-2-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohepta-2,4,6-trien-1-one

C16H22O7 (326.1365)


   

(5r)-4-hydroxy-3-[(4s)-4-hydroxy-1-[(5r)-4-hydroxy-5-methyl-2-oxo-5h-furan-3-yl]hexyl]-5-methyl-5h-furan-2-one

(5r)-4-hydroxy-3-[(4s)-4-hydroxy-1-[(5r)-4-hydroxy-5-methyl-2-oxo-5h-furan-3-yl]hexyl]-5-methyl-5h-furan-2-one

C16H22O7 (326.1365)


   

(3z)-7-(acetyloxy)-6-hydroxy-2-methyl-10-oxo-2,5,6,7,8,9-hexahydrooxecin-5-yl (2e)-but-2-enoate

(3z)-7-(acetyloxy)-6-hydroxy-2-methyl-10-oxo-2,5,6,7,8,9-hexahydrooxecin-5-yl (2e)-but-2-enoate

C16H22O7 (326.1365)


   

(1s,2s)-1-(acetyloxy)-1-(2,4,5-trimethoxyphenyl)propan-2-yl acetate

(1s,2s)-1-(acetyloxy)-1-(2,4,5-trimethoxyphenyl)propan-2-yl acetate

C16H22O7 (326.1365)


   

8,10,11-trihydroxy-6-(methoxymethyl)-1,10-dimethyl-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-5-one

8,10,11-trihydroxy-6-(methoxymethyl)-1,10-dimethyl-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-5-one

C16H22O7 (326.1365)


   

7-hydroxy-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methylisoquinolin-2-ium

7-hydroxy-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methylisoquinolin-2-ium

[C19H20NO4]+ (326.1392)


   

2-(hydroxymethyl)-6-[2-methoxy-4-(prop-1-en-1-yl)phenoxy]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[2-methoxy-4-(prop-1-en-1-yl)phenoxy]oxane-3,4,5-triol

C16H22O7 (326.1365)


   

2-(hydroxymethyl)-6-[4-(3-methoxyprop-1-en-1-yl)phenoxy]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[4-(3-methoxyprop-1-en-1-yl)phenoxy]oxane-3,4,5-triol

C16H22O7 (326.1365)


   

1,9-dihydroxy-13-(methoxymethyl)-7,10-dimethyl-2,5-dioxatricyclo[8.4.0.0³,⁸]tetradec-12-ene-4,14-dione

1,9-dihydroxy-13-(methoxymethyl)-7,10-dimethyl-2,5-dioxatricyclo[8.4.0.0³,⁸]tetradec-12-ene-4,14-dione

C16H22O7 (326.1365)


   

6-isopropyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohepta-2,4,6-trien-1-one

6-isopropyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohepta-2,4,6-trien-1-one

C16H22O7 (326.1365)


   

(2s,3s,4ar,6r,7r,8s,8ar)-6-(hydroxymethyl)-2-(4-methoxyphenyl)-3-methyl-hexahydro-2h-pyrano[2,3-b][1,4]dioxine-7,8-diol

(2s,3s,4ar,6r,7r,8s,8ar)-6-(hydroxymethyl)-2-(4-methoxyphenyl)-3-methyl-hexahydro-2h-pyrano[2,3-b][1,4]dioxine-7,8-diol

C16H22O7 (326.1365)


   

(3r,4r)-4,8-dihydroxy-3-[(2r)-2-hydroxypentyl]-6,7-dimethoxy-3,4-dihydro-2-benzopyran-1-one

(3r,4r)-4,8-dihydroxy-3-[(2r)-2-hydroxypentyl]-6,7-dimethoxy-3,4-dihydro-2-benzopyran-1-one

C16H22O7 (326.1365)